SINT
Sintx Technologies, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$1.70
−2.30%Year over year
Reported trailing growth
- Revenue
- +0.2%
- EBITDA
- +8.4%
- EBIT
- +10.8%
- EPS
- +47.6%
- Free cash flow
- -35.6%
- Operating cash flow
- -36.7%
Forward estimates
Based on analyst estimates
- Revenue
- +206.6%
- EBITDA
- +55.1%
- EPS
- +78.4%
Three-year CAGR
- Revenue
- +19.2%
- EBITDA
- -0.4%
- EBIT
- +23.7%
- Net income
- -55.0%
- EPS
- +58.6%
- Free cash flow
- +6.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026